Vaccinating in the Emergency Department, a Novel Approach to Improve Influenza Vaccination Rates via a Quality Improvement Initiative.
Journal
Pediatric quality & safety
ISSN: 2472-0054
Titre abrégé: Pediatr Qual Saf
Pays: United States
ID NLM: 101702480
Informations de publication
Date de publication:
Historique:
received:
31
03
2020
accepted:
09
06
2020
entrez:
9
8
2020
pubmed:
9
8
2020
medline:
9
8
2020
Statut:
epublish
Résumé
Annual influenza vaccination is recommended for all US children 6 months and older to prevent morbidity and mortality. Despite these recommendations, only ~50% of US children are vaccinated annually. Influenza vaccine administration in the pediatric emergency department (ED) is an innovative solution to improve vaccination rates. However, during the 2017-2018 influenza season, only 75 influenza vaccinations were given in this tertiary care ED. We aimed to increase the number of influenza vaccines administered to ED patients from 75 to 1,000 between August 2018 and March 2019.s. Process mapping identified potential barriers and solutions. Key interventions included mandatory vaccine screening, creation of a vaccine administration protocol, education for family, provider, and nursing, a revised pharmacy workflow, and weekly staff feedback. Interventions were tested using plan-do-study-act cycles. The process measure was the percent of patients screened for vaccine status. The primary outcome was the number of influenza vaccines administered. The balancing measures were ED length of stay (LOS), wasted vaccines, and financial impact on the institution. We included 33,311 children in this study. Screening for vaccine status improved from 0% to 90%. Of those screened, 58% were eligible for vaccination, and 8.5% of eligible patients were vaccinated in the ED. In total, 1,323 vaccines were administered with no significant change in ED LOS (139 min) and no lost revenue to the hospital. We implemented an efficient, cost-effective, influenza vaccination program in the pediatric ED and successfully increased vaccinations in a population that might not otherwise receive the vaccine.
Identifiants
pubmed: 32766495
doi: 10.1097/pq9.0000000000000322
pmc: PMC7351463
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e322Informations de copyright
Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc.
Références
Pediatrics. 2018 Oct;142(4):
pubmed: 30177511
Vaccine. 2010 Aug 23;28(37):6058-64
pubmed: 20620167
Public Health. 2018 May;158:1-8
pubmed: 29524610
JAMA Pediatr. 2018 Jan 2;172(1):e173879
pubmed: 29114729
MMWR Recomm Rep. 2018 Aug 24;67(3):1-20
pubmed: 30141464
Pediatrics. 2001 Feb;107(2):E17
pubmed: 11158491
Hosp Pediatr. 2016 Sep;6(9):513-9
pubmed: 27577991
Pediatrics. 2017 May;139(5):
pubmed: 28557757
Vaccine. 2018 Jun 22;36(27):3960-3966
pubmed: 29801998
Pediatrics. 2018 Apr;141(4):
pubmed: 29440502
J Infect Dis. 2014 Sep 1;210(5):674-83
pubmed: 24676207
Pediatrics. 2004 Jun;113(6 Suppl):1959-64
pubmed: 15173467
Vaccine. 2015 Apr 8;33(15):1802-7
pubmed: 25744225
Cochrane Database Syst Rev. 2018 Feb 01;2:CD004879
pubmed: 29388195
Influenza Other Respir Viruses. 2018 May;12(3):416-420
pubmed: 28872773
Vaccine. 2012 Mar 23;30(14):2448-52
pubmed: 22300721
Public Health Rep. 2018 Nov;133(6):667-676
pubmed: 30300560
J Adolesc Health. 2011 Aug;49(2):133-40
pubmed: 21783044
Vaccine. 2015 Jun 17;33(27):3114-21
pubmed: 25979804
Vaccine. 2014 Nov 12;32(48):6364-8
pubmed: 24962754
J Pediatr Health Care. 2016 May-Jun;30(3):208-15
pubmed: 26254743
Pediatrics. 2006 Nov;118(5):e1287-92
pubmed: 17079529